298380.KQ
ABL Bio Inc. [298380.KQ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
298380.KQ Stock Summary
Top 10 Correlated ETFs
298380.KQ
Top 10 Correlated Stocks
298380.KQ
In the News
298380.KQ Financial details
Company Rating
-
Market Cap
1103.92B
Income
-2.65B
Revenue
65.55B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
93
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-143.94
Forward P/E
-
PEG
7.96
P/S
17.01
P/B
13.36
P/C
-
P/FCF
818.21
Quick Ratio
0.38
Current Ratio
1.08
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-54.49
EPS next Y
-
EPS next Q
-
EPS this Y
-182%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-41.66%
Revenue last 5Y
75.04%
Revenue Q/Q
-6.6%
EPS Q/Q
204.34%
-
-
-
-
SMA20
93.08%
SMA50
65.87%
SMA100
143.78%
Inst Own
-
Inst Trans
-
ROA
-5%
ROE
-9%
ROC
-0.04%
Gross Margin
100%
Oper. Margin
-6%
Profit Margin
-12%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
15370.0-30500.0
52W High
+113.77%
52W Low
+324.2%
RSI
66.24
Rel Volume
0.6
Avg Volume
1.03M
Volume
616.44K
Perf Week
0.46%
Perf Month
60.79%
Perf Quarter
81.87%
Perf Half Y
77.66%
-
-
-
-
Beta
1.08
-
-
Volatility
1598.98%, 14314.97%
Prev Close
-3.12%
Price
65200
Change
-0.91%
Company Profile
- Volume Average 1.03M
- Market Capitalization 1103.92B
- Employee 93
- CEO Dr. Sang Hoon Lee Ph.D.
- Headquarters Seongnam,KR
- IPO Date 2018-12-19
-
Website
http://www.ablbio.com 
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. The company is headquartered in Seongnam, South Korea.
